|
2010 Releases
January 15, 2010
NUCRYST Announces Distribution of Supplemental Information In Connection with Special Meeting of Shareholders
2009 Releases
December 22, 2009
NUCRYST Announces Completion of the Sale of its Acticoat Business
November 20, 2009
NUCRYST Announces Special Meeting of Shareholders
November 13, 2009
NUCRYST announces 2009 third quarter financial results
November 10, 2009
NUCRYST Announces Agreement to Sell Acticoat Business and Proposes Amalgamation with Westaim
September 18, 2009
NUCRYST Receives Deficiency Notice from NASDAQ
September 03, 2009
European Launch of Acticoat™ Flex with NUCRYST’s Nanocrystalline Silver Technology Announced by Smith & Nephew
August 05, 2009
NUCRYST announces 2009 second quarter financial results
July 29, 2009
New ACTICOAT™ Silver Coated Anti-microbial Barrier Dressing
Receives 510(k) Clearance from the US FDA
July 21, 2009
Conference Call to Discuss 2009 Second Quarter Results
May 6, 2009
NUCRYST announces 2009 first quarter financial results
April 29, 2009
NUCRYST Pharmaceuticals Corp.
Conference Call to Discuss 2009 First Quarter Results
February 17, 2009
NUCRYST Announces Fourth Quarter and Year End 2008 Financial Results
February 12, 2009
NUCRYST Approves $0.80 Per Share Cash Distribution to Shareholders
February 9, 2009
NUCRYST Pharmaceuticals Corp. Conference Call to Discuss 2008 Fourth Quarter and Full Year Results
January 19, 2009
NUCRYST appoints interim CEO
January 16, 2009
NUCRYST Pharmaceuticals appoints a new director
2008 Releases
December 19, 2008
NUCRYST Calls Special Meeting of Shareholders
December 02, 2008
NUCRYST Receives Requisition to Call a Special Meeting of Shareholders From Majority Shareholder
November 07, 2008
New Acticoat™ Silver Coated Anti-microbial Barrier Dressing Receives Regulatory Approval from Health Canada
November 6, 2008
NUCRYST Announces Third Quarter 2008 Financial Results
October 24, 2008
NUCRYST Pharmaceuticals to Release Third Quarter 2008 Financial Results on Thursday, November 6, 2008
|
